Pluristem Therapeutics Inc
PSTI
Get informed when a big investor buys or sells
+ FollowMarket Cap$40.85M
Close$
$2.11
111.1% upside
Current Fair Value
111.1% upsideUndervalued by 111.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $40.85 Million |
|---|---|
| Enterprise Value | $44.87 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.44 |
| Beta | 1.91 |
| Outstanding Shares | 9,743,913 |
Return
| Return on Equity | 110.13% |
|---|---|
| Return on Assets | -157.10% |
| Return on Invested Capital | 152.57% |
Valuation & Multiples
| P/E Ratio | -0.41 |
|---|---|
| PEG | 0.24 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 44.16 |
| Enterprise Value to EBIT | -1.77 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | -0.33 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Pluristem Therapeutics Inc
CEO: Yaky Yanay